🕵️ Immucell Corp /DE/ ($ICCC)
SEC insider & ownership activity, last 12 months · CIK 811641 · every row links its SEC filing
Over the last 12 months insiders bought $172K with no open-market selling against it. TE Boekhorst PAUL Francis Olivier bought $156K (Dec–Jun). 2 red-flag 8-Ks in the window, most recently Impairment (2.06), Jan 8, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $172K (8 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| TE Boekhorst PAUL Francis Olivier | 6 | $156K | 0 | – | Jun 18, 2026 |
| Tomsche David Scott | 2 | $16K | 0 | – | Nov 25, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ejnar A. Knudsen III | 9.2% | 13D | Nov 19, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | May 8, 2026 | filing ↗ |
| Earnings (2.02) | Apr 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 8, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 7, 2026 | filing ↗ |
| Other events (8.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Earnings (2.02) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Earnings (2.02) | Jan 8, 2026 | filing ↗ |
| Impairment (2.06) | Jan 8, 2026 | filing ↗ |
| Other events (8.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Impairment (2.06) | Dec 24, 2025 | filing ↗ |
| Other events (8.01) | Dec 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 24, 2025 | filing ↗ |